Sector: Medical Devices / Orthopedics
Platform: StartEngine
Stage: Growth
Minimum Investment: $497
What They Do
Acuitive Technologies develops next-generation bioabsorbable orthopedic implants that promote natural healing and gradually dissolve in the body, eliminating the need for removal surgeries.
Why It Might Be the Next Big Thing
Most orthopedic implants are made from metal and often require secondary surgeries for removal. Acuitive’s citrate-based biomaterials stimulate bone growth and resorb safely, reducing complications and recovery time.
Snapshot
8,000+ patients already treated with Acuitive technology
Raising $5M on StartEngine to scale treatment access to 80,000+ patients
FDA 510(k) clearance for its CITREGRAFT bone graft substitute
Valuation around $60.8M
Led by a team with decades in orthopedic innovation and biomaterials
My Take
Orthopedic medicine is finally catching up with regenerative innovation. Acuitive’s proven patient base and FDA clearance give it credibility rare for a medtech crowdfunding raise.
📖 Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice or investment solicitation.